ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VVY Vivoryon Therapeut

0.82
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Vivoryon Therapeut VVY Euronext Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.82 15:35:12
Open Price Low Price High Price Close Price Previous Close
0.82
more quote information »

Recent News

Date Time Source Heading
24/4/202415:00GLOBEVivoryon Therapeutics N.V. Reports Full Year 2023 Financial..
16/4/202415:00GLOBEVivoryon Therapeutics N.V. to Report Full Year 2023..
15/3/202417:00GLOBEVivoryon Therapeutics N.V. Announces Changes to Board..
04/3/202417:00GLOBEVivoryon Therapeutics N.V. Provides Update on VIVIAD Phase..
08/1/202417:00GLOBEVivoryon Therapeutics N.V. to Host Investor Meetings in..
06/12/202317:00GLOBEVivoryon Therapeutics N.V. Reports Third Quarter 2023..
28/11/202317:00GLOBEVivoryon Therapeutics N.V. to Report Q3 2023 Financial..
07/11/202317:00GLOBEVivoryon Therapeutics N.V. to Present at Upcoming Investor..
26/10/202316:00GLOBEVivoryon Therapeutics N.V. Provides Comprehensive Progress..
23/10/202316:00GLOBEVivoryon Therapeutics N.V. Reports Positive Outcome from..
18/10/202300:32GLOBEVivoryon Therapeutics N.V. Shares Highlights from Virtual..
05/10/202316:00GLOBEVivoryon Therapeutics N.V. Announces Virtual R&D Event with ..
15/9/202321:57GLOBEVivoryon Therapeutics N.V. Extraordinary General Meeting..
07/9/202315:00GLOBEVivoryon Therapeutics N.V. Reports H1 2023 Financial Results..
31/8/202315:00GLOBEVivoryon Therapeutics N.V. to Report Half Year 2023..
05/8/202307:35GLOBEVivoryon Therapeutics N.V. Extraordinary General Meeting to..
05/8/202307:30GLOBEVivoryon Therapeutics N.V. Announces Proposed Appointment of..
16/7/202317:00GLOBEVivoryon Therapeutics N.V. Shares Clinical Development..
22/6/202302:02GLOBEVivoryon Therapeutics N.V. Reports Outcome of 2023 Annual..
16/6/202301:49GLOBEVivoryon Therapeutics N.V. Announces CEO Transition Plan
01/6/202315:00GLOBEVivoryon Therapeutics N.V. to Participate in Upcoming..
26/5/202315:39GLOBEVivoryon Therapeutics Successfully Completes Private..
26/5/202301:50GLOBEVivoryon Therapeutics Launches Capital Increase by Way of an..
16/5/202315:00GLOBEVivoryon Therapeutics N.V. Reports Q1 2023 Financial Results..
09/5/202315:02GLOBEVivoryon Therapeutics N.V. to Hold its 2023 Annual General..
09/5/202315:00GLOBEVivoryon Therapeutics N.V. to Report Q1 2023 Financial..
01/5/202318:00GLOBEVivoryon Therapeutics N.V. Announces Planned Changes to..

Your Recent History

Delayed Upgrade Clock